Belatacept and Outcomes in Kidney Transplantation

NEJM Group
NEJM Group
3.9 هزار بار بازدید - 9 سال پیش - Immunosuppressive therapy in patients with
Immunosuppressive therapy in patients with kidney transplants has reduced the incidence of allograft rejection, but standard therapy may not adequately preserve allograft function. Would a different regimen improve outcomes? Learn more at http://nej.md/1ny5QsU
9 سال پیش در تاریخ 1394/11/08 منتشر شده است.
3,975 بـار بازدید شده
... بیشتر